ABSTRACT A fluorescent analogue of ceramide, N-[7-(4-nitrobenzo-2-oxa-1,3-diazole)]-e-aminocaproyl sphingosine (C6-NBDceramide), was used to investigate sphingolipid metabolism in Chinesehamster fibroblasts. C6-NBD-ceramide was incorporated into small unilamellar dioleoyl phosphatidylcholine vesicles and incubated with cells in monolayer culture at 20C, resulting in rapid and preferential transfer of the labeled ceramide from vesicles to cells. The cells were then washed and subsequently incubated at 37°C for various intervals. The metabolism of C6-NBD-ceramide was monitored by lipid extraction and analysis, and the intracellular distribution of the labeled molecule was followed by fluorescence microscopy. Initially, fluorescence was detected almost exclusively in mitochondria, with over 90% of the extractable lipid fluorescence due to C6-NBD-ceramide. After 30 min at 370C, intense fluorescence. appeared in the Golgi apparatus. This organelle was identified by colocalization of NBD fluorescence with a Golgi-apparatus-specific stain. At later times the plasma membrane became visibly labeled as well, at which point 90% of the cell-associated fluorescence was recovered as NBD-labeled sphingomyelin and NBD-labeled cerebroside. These metabolites were identified by enzymatic and biochemical analysis and by thin-layer chromatography of the fluorescent lipid extracts. The finding that C6-NBD-ceramide is used by these cells in standard pathways of sphingolipid biosynthesis suggests that this fluorescent precursor will be a valuable tool for correlating the metabolism of sphingolipids with their intracellular distribution and translocation. In addition, during its metabolism by Chinese hamster fibroblasts, this compound acts as a vital stain for the Golgi apparatus. orescent tracer allows direct microscopic observation of the translocation and sequestering of the labeled precursor and its metabolites as it occurs in living cells. Thus, artifacts and delays due to tissue fixation or subcellular fractionation are avoided.
orescent tracer allows direct microscopic observation of the translocation and sequestering of the labeled precursor and its metabolites as it occurs in living cells. Thus, artifacts and delays due to tissue fixation or subcellular fractionation are avoided.
Here we report that C6-NBD-ceramide is metabolized by cultured fibroblasts to fluorescently labeled sphingomyelin and cerebroside. During this metabolism, the intracellular distribution of fluorescence, involving the mitochondria, Golgi apparatus, and plasma membrane, also changes in a striking man- ner.
The sphingolipids are important membrane lipids which have been implicated in a number of cellular properties, including blood group specificity, receptor action, nerve conduction, membrane stability, oncogenic transformation, and aging (for reviews see refs. [1] [2] [3] [4] . Although all of the biosynthetic pathways for the sphingolipids are not yet completely understood (5) (6) (7) , it is well known that defects in their metabolism or breakdown can have serious consequences, such as Tay-Sachs or Farber diseases (8, 9) . All the sphingolipids have in common the ceramide backbone, which is either.glycosylated to yield cerebrosides and gangliosides or coupled to phosphocholine to give sphingomyelin. The sites of synthesis of these molecules inside the cell remain to be determined, as do the molecular mechanisms underlying translocation and insertion of the different sphingolipids into different subcellular membranes.
In order to examine the correspondence between sphingolipid metabolism and the intracellular distribution of these lipids, we have initiated a study using N-[7-(4-nitrobenzo-2-oxa-1,3-diazole)]-6-aminocaproyl sphingosine (C6-NBD-ceramide), a fluorescent derivative of ceramide (Fig. 1) . The use of a flu-METHODS Materials. Chemicals were purchased as indicated: Clostridium perfringens phospholipase C, human placenta sphingomyelinase, taurodeoxycholate, sphingosine-l-phosphocholine, psychosine, and bovine brain sphingolipids (Sigma); Eagle's minimal essential medium (GIBCO); lectins (Vector Laboratories, Burlingame, CA); and rhodamine 3B (Eastman).
Lipids and Lipid Vesicles. N-Rhodamine B sulfonyl dioleoyl phosphatidylethanolamine (N-Rh-PtdEtn) was synthesized as described (10) . C6-NBD-ceramide, C6-NBD-galactosylceramide, and NBD-sphingomyelin were synthesized (9), using sphinAbbreviations: NBD, 4-nitrobenzo-2-oxa-1,3-diazole; NBD-sphingomyelin, N-[7-(4-nitrobenzo-2-oxa-1,3-diazole)]aminoacyl sphingosine-1-phosphocholine; NBD-cerebroside, N-[7-(4-nitrobenzo-2-oxa-1,3-diazole)]aminoacyl-sphingosine monoglycoside; C6-NBD fatty acid, N-[7-(4-nitrobenzo-2-oxa-1,3-diazole)]-6-aminocaproic acid; C6-NBD-ceramide, N-[7-(4-nitrobenzo-2-oxa-1,3-diazole)]-6-aminocaproyl sphingosine; C6-NBD-galactosylceramide, N-[7-(4-nitrobenzo-2-oxa-1,3-diazole)]-6-aminocaproyl sphingosine galactoside; N-Rh-PtdEtn, N-rhodamine B sulfonyl dioleoyl phosphatidylethanolamine; Oe2-PtdCho, dioleoyl phosphatidylcholine; HMEM, 18 mM Hepes-buffered Eagle's minimal essential medium, pH 7.4, with 0.62 mM phosphate; HMEMB, HMEM with choline, ethanolamine, serine, and myo-inositol at 0.5 mM each.
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The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. (25) were performed. RESULTS Cellular Uptake of C6-NBD-Ceramide from Vesicles. When cells were incubated at 20C with vesicles containing Ole2-PtdCho, C6-NBD-ceramide, and the nonexchangeable lipid N-Rh-PtdEtn (10, 14, 26) , there was a rapid and preferential uptake of the fluorescent ceramide by the cells. The ratio of NBD to rhodamine in the cell lipid extract was approximately 10 times that of the added vesicles for two different concentrations of C6-NBDceramide (Table 1) . Thus, NBD uptake by cells was due primarily to uptake of C6-NBD-ceramide molecules rather than mere association of intact vesicles with cells. If the latter had been the case, the ratio of NBD to rhodamine in the cells would have been the same as that of the initial vesicle suspension (27) .
Metabolism of C6-NBD-Ceramide. When cells were incubated with C6-NBD-ceramide-containing vesicles for 90 min at 20C, washed, and incubated at 37°C for 1 hr, three major fluorescent products appeared in the lipid extracts. Fig. 2 shows a two-dimensional chromatogram of such an extract, with the fluorescent spots "C,' "Cb," and "Sm" labeled. The three products were identified as C6-NBD-ceramide, NBD-cerebro- side, and NBD-sphingomyelin, respectively (Table 2) . After acid hydrolysis, 90-100% of the fluorescence of each of the three spots was recovered as a mixture of C6-NBD fatty acid and its methyl ester, indicating that the fluorescence of all the compounds was due to C6-NBD fatty acid. The appearance of free fatty acid and its methyl ester are expected after acid hydrolysis of sphingolipids. When all three fluorescent products were subjected to periodate oxidation followed by sodium borohydride reduction and acid hydrolysis, a procedure that results in the removal of the sugar residue of cerebrosides (25) , only Cb was altered. This procedure transformed Cb into a fluorescent compound that had the chromatographic properties of C6-NBDceramide; thus, Cb was identified as NBD-cerebroside. This NBD-cerebroside was tentatively defined as glucocerebroside, on the basis of its behavior on borate-treated silica gel thin-layer plates (28) . In solvent 3, bovine brain galactocerebroside and synthetic C6-NBD-galactosylceramide are reduced in mobility on borate-treated plates. In contrast, glucocerebroside has increased mobility. NBD-cerebroside manifested an increase in mobility similar to that of glucocerebroside (data not shown). quantified after the incubation of monolayers with vesicles for 90 min at 20C, rinsing, and subsequent incubation at 37C in HMEMB for various times. Total fluorescence was determined in the lipid extracts at each time point, then equal amounts of fluorescent extracts from each point were subjected to thin-layer chromatography. The percent of the total recovered fluorescence due to each sphingolipid at each time point is shown in Fig. 3 . Within 1 hr after the shift to 37°C, C6-NBD-ceramide declined from about 90% of the total fluorescence to about 10%. Both NBD-cerebroside and NBD-sphingomyelin increased to about 45% of the total within this time period. The relative levels at 2 hr remained unchanged at 4 hr (data not shown).
The amount of total extractable NBD fluorescence found in cultures over this time course declined from 100% after 90 min at 20C to approximately 50% after further incubation for 1 hr at 370C (Table 3) . Furthermore, the lost fluorescence could not be recovered by extraction of the medium. This decline was not seen when cultures were maintained at 20C. Varying the extraction procedure, or examining the aqueous phases, did not result in increased fluorescence recovery (not shown). These results suggest that one or more of the labeled metabolites was rendered nonfluorescent at 37C. Intracellular Distribution of Fluorescence. Fig. 4 demonstrates the appearance of labeled fibroblasts during the time course described above. Immediately after incubation with C6-NBD-ceramide at 2°C (Fig. 4A) , NBD fluorescence was largely localized in cytoplasmic structures. After 10-30 min at 37C (Fig. 4B) , bright areas of punctate fluorescence appeared, adjacent to, or over, the nucleus. At later times, the plasma membrane also became highly labeled. Although the total cell-associated fluorescence decreased after 30-60 min (see above), the labeling pattern was maintained (Fig. 4C) . The plasma membrane could be clearly observed by focusing in a plane beyond the nucleus (Fig. 4D) .
To identify highly labeled structures, colocalization studies were performed with stains known to be specific for different subcellular organelles. After incubation with C6-NBD-ceramide at 20C, cells were briefly labeled with rhodamine 3B, a mitochondrial marker (16) . Fig. 5 demonstrates the remarkable coincidence of staining provided by these labels and indicates that most of the NBD fluorescence was located in the mitochondria. The independent behavior of these two stains and the lack of crossover between the separate fluorescence channels were confirmed with appropriate controls. In addition, the appearance of mitochondria stained with either fluorophore was similar to that seen with Janus green (29) , a classical mitochondrial vital stain (not shown). Fig. 6 demonstrates that the bright punctate fluorescence seen at 370C (corresponding to Fig. 4 B and C) was located in the Golgi apparatus. This fluorescence colocalizes with that obtained in the same preparation after labeling with rhodamineconjugated wheat germ agglutinin, a lectin specific for the Golgi apparatus (17) . The same rhodamine pattern was obtained in the presence or absence of NBD, indicating that this lectin was not merely binding to NBD-sphingolipid (data not shown).
DISCUSSION
This study has shown that a fluorescent derivative of the sphingolipid precursor ceramide was taken up by cultured fibroblasts from phospholipid vesicles. The ceramide analogue was converted to fluorescent derivatives of cerebroside and sphingomyelin, products expected from the known pathways (3) Our findings that C6-NBD-ceramide was metabolized by cells along expected pathways and that it and its products were translocated within cells strongly suggest that the NBD label did not drastically interfere with the cell's ability to metabolize the ceramide moiety. This is consistent with recent studies (19, 30) , which used an NBD-labeled derivative of phosphatidic acid to show that it, too, is metabolized to yield a characteristic set of fluorescent products, with a pattern of intracellular labeling very different from that reported here. The results reported here appear to be specific to the ceramide base, rather than the NBD moiety, and are consistent with C6-NBD-ceramide acting as a reliable functional analogue for ceramide.
A significant finding of this study is that, as C6-NBD-ceramide was metabolized during incubations at 37TC, the intracellular distribution of fluorescence changed in a gradual and progressive fashion, first involving mitochondria, then the Golgi apparatus, and later the plasma membrane as the dominantly labeled structures in the cell. Although this redistribution of fluorescence seemed to correlate directly with the synthesis of NBD-sphingomyelin and NBD-cerebroside, we do not as yet know the precise subcellular location of each of these NBD-labeled compounds. However, because many glycosyltransferases (31) (32) (33) (34) are located in the Golgi apparatus, it seems reasonable to expect that the NBD-cerebroside was synthesized there prior to translocation to the cell surface or elsewhere. Because NBD-sphinogmyelin was present in lipid extracts in significant amounts prior to intense labeling of the cell surface, it can be argued that it is first synthesized intracellularly (4, 6, 34, 35) , then transported to the cell surface. Plasma membrane labeling became most conspicuous after about 30 min at 37TC, consistent with the length of time reported for an isotopically labeled neuronal ganglioside (32) , to appear at the plasma membrane. However, is is also possible that fluorescent labeling of the plasma membrane occurred at much earlier times but was obscured by the very bright fluorescence of the cytoplasm. Consistent with this possibility are recent reports by Marggraf et al. (7), and Voelker and Kennedy (36) , which suggest that the plasma membrane is the primary site of synthesis of sphingomyelin. Studies to detect the appearance with time of NBDsphingomyelin at the cell surface may resolve this issue.
Finally, in addition to providing a means for investigating sphingolipid metabolism and translocation in cells, fluorescent ceramide may be useful as a vital stain for the Golgi apparatus.
